On Apr 30, 2026, DBD reported earnings of 0.67 USD per share (EPS) for Q1 26, beating the estimate of 0.62 USD, resulting in a 7.86% surprise. Revenue reached 888.20 million, compared to an expected 866.12 million, with a 2.55% difference. The market reacted with a -7.41% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 3 analysts forecast an EPS of 1.11 USD, with revenue projected to reach 935.63 million USD, implying an increase of 65.67% EPS, and increase of 5.34% in Revenue from the last quarter.